RACHEL GERARDY: Open Payments
NPI 1730655812 · ANNANDALE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,940 in 97 payments from 18 companies in 2025. Trend: 2023 $816 · 2024 $1,748 · 2025 $1,940
Food & beverage: $1,865Education: $75
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $483 |
| Janssen Biotech, Inc. | 10 | $286 |
| Amgen Inc. | 13 | $220 |
| E.R. Squibb & Sons, L.L.C. | 8 | $155 |
| PFIZER INC. | 11 | $149 |
| UCB, Inc. | 4 | $106 |
| Aurinia Pharma U.S., Inc. | 3 | $87 |
| Invivyd Inc | 3 | $83 |
| AstraZeneca Pharmaceuticals LP | 1 | $77 |
| Organon LLC | 3 | $69 |
Products named: RINVOQ, TREMFYA, ORENCIA, SKYRIZI, XELJANZ, KRYSTEXXA, Bimzelx, LUPKYNIS.
Industry payments across VA — which companies pay providers there.
